Equal-Weight Recommendation Issued On MRKR By Barclays
Source: KlickAnalytics
2025-03-05 13:30:03 ET
Historical Analyst Recommendations
Latest 10 recommendations| Report Date | Full story available on KlickAnalytics.com
Marker Therapeutics Inc.
NASDAQ: MRKR
MRKR Trading
-2.55% G/L:
$1.335 Last:
43,554 Volume:
$1.36 Open:
MRKR Latest News
February 18, 2026 08:00:00 am
Marker Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
January 26, 2026 07:00:00 am
Good Morning America Features Baylor College of Medicine Pancreatic Cancer Study Utilizing Marker Therapeutics' MAR-T Cell Technology
January 05, 2026 07:00:00 am
Baylor College of Medicine Publishes Promising Safety and Efficacy Results of Multi-Antigen Targeted T Cells in Patients with Pancreatic Cancer
November 14, 2025 07:00:00 am
Marker Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates
MRKR Stock Data
$25,759,981
15,372,623
3.36%
21
N/A
Biotechnology & Life Sciences
Healthcare
US
Houston
